Kevin Herde

Former Chief Financial OfficeratMaravai Lifesciences Holdings· In proxies 2021–2025

Pay in FY2025-26% from the year before · Maravai Lifesciences Holdings stock -40.4% the same year

Kevin Herde was paid $1.7M in FY2025 (Dec), down 26%. Maravai Lifesciences Holdings stock fell 40.4% that year.

Pay$100 in the stock at the end of FY20 → $12

Pay is from the Summary Compensation Table of each Maravai Lifesciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

MRVI
Maravai Lifesciences HoldingsPublic company · 5 yr
- Former Chief Financial Officer2021 – Present · 5 yrStock in role -71%

Roles come from the proxy statements of each company.

Activity

Pay
Maravai Lifesciences Holdings Former CFO pay fell 26% to $1.7M. The stock fell 40% in FY2025 (Dec).
DEF 14AApr 24, 2026
Pay
Maravai Lifesciences Holdings Former CFO pay fell 16% to $2.3M. The stock fell 17% in FY2024 (Dec).
DEF 14AApr 18, 2025
Pay
Maravai Lifesciences Holdings Former CFO pay rose 60% to $2.8M. The stock fell 54% in FY2023 (Dec).
DEF 14AApr 25, 2024
Pay
Maravai Lifesciences Holdings Former CFO pay rose 107% to $1.7M. The stock fell 66% in FY2022 (Dec).
DEF 14AApr 25, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?